Kawabeta Koji, Yuasa Masahiro, Sugano Michihiro, Koba Kazunori
Graduate School of Human Health Science, University of Nagasaki, Siebold, Nagasaki 851-2915, Japan.
Department of Health and Nutrition, Faculty of Health Management, Nagasaki International University, 2825715 Huis Ten Bosch, Nagasaki 859-3298, Japan.
Metabolites. 2022 May 8;12(5):422. doi: 10.3390/metabo12050422.
Dietary β-conglycinin has been shown to increase plasma adiponectin concentration and decrease visceral adipose tissue weight in rats. Since adiponectin is one of the factors regulating blood pressure, as well as modulating lipid metabolism, we examined whether dietary β-conglycinin affects blood pressure in spontaneously hypertensive rats. The experimental diets were prepared according to the AIN-93G formula containing 20% protein, either casein (Control) or casein replaced with soy protein isolate (SOY) or β-conglycinin (β-CON) at the proportion of 50%. Male rats (SHR/Izm, 6 wk-old) were fed the diets for 7 weeks. The SOY compared with the Control significantly suppressed the blood pressure both at week 4 ( = 0.011, Control vs. SOY) and thereafter, and β-CON had even higher suppression ( = 0.0002, Control vs. β-CON). SOY and β-CON increased plasma adiponectin concentration followed by an increase in plasma nitric oxide and possibly a decreasing trend of gene expressions of angiotensinogen in the liver and renin in the kidney. The results indicated suppression by β-conglycinin of increasing blood pressure through an enhancement of plasma adiponectin, probably in combination with a regulation of the renin-angiotensin system in spontaneously hypertensive rats.
膳食β-伴大豆球蛋白已被证明可提高大鼠血浆脂联素浓度并降低其内脏脂肪组织重量。由于脂联素是调节血压以及调节脂质代谢的因素之一,因此我们研究了膳食β-伴大豆球蛋白是否会影响自发性高血压大鼠的血压。按照AIN-93G配方制备实验饮食,其蛋白质含量为20%,分别为酪蛋白(对照)或用大豆分离蛋白(SOY)或β-伴大豆球蛋白(β-CON)以50%的比例替代酪蛋白。雄性大鼠(SHR/Izm,6周龄)喂食这些饮食7周。与对照组相比,SOY在第4周(P = 0.011,对照 vs. SOY)及之后显著抑制了血压,而β-CON的抑制作用更强(P = 0.0002,对照 vs. β-CON)。SOY和β-CON提高了血浆脂联素浓度,随后血浆一氧化氮增加,肝脏中血管紧张素原和肾脏中肾素的基因表达可能呈下降趋势。结果表明,在自发性高血压大鼠中,β-伴大豆球蛋白可能通过增强血浆脂联素并可能与肾素-血管紧张素系统的调节相结合来抑制血压升高。